Cipla shares broke out above ₹1,580–₹1,590 on strong volumes, with technical indicators signaling further gains.

CHENNAI: Indian equity markets ended Thursday’s session with modest gains, supported by financials and Reliance Industries, ...

An update from Theravance Biopharma ( ($TBPH) ) is now available. On August 15, 2025, Theravance Biopharma and Mylan entered into a Settlement ...

Zee Business analysts Ansh Jogendra Bhilwar and Pooja Tripathi have shared a number of calls for trading and investing today, ...

With sweeping duties taking effect Aug. 27, India faces billions in losses, mass job cuts, and shrinking competitiveness in ...

According to Elara Capital’s Domestic Liquidity Tracker, the changes in pharma and tech were led by HDFC MF, ICICI Prudential MF, and SBI Mutual Fund.

Nifty Pharma index closed up 0.95% at 22177.7 today. The index is down 1.00% over last one month. Among the constituents, Mankind Pharma Ltd gained 3.73%, Cipla Ltd jumped 3.02% and Dr Reddys ...

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD)Appro ...

This is but a fact that obesity drugs are only going to get more accessible for Indians post March 2026. But whether they ...

Overview Nifty 50 closed above 25,100, driven by IT sector strength and strong support from financials and pharma ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Patrik Ling has joined the ...

Market expert Ankush Bajaj shares his top three stock recommendations for Friday, 22 August. Discover his exclusive picks and ...